Related Experiment Video
Updated: Feb 10, 2026
Measuring Proliferation of Vascular Smooth Muscle Cells Using Click Chemistry
Published on: October 30, 2019
[Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells]
Chenlong Zhao1, Minghui Liu1, Yongwen Li2
1Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.
Background:
Angiogenesis is an important process in the development of tumor. PD 0332991, a cell cycle inhibitor, can specifically inhibit CD4/6 phosphorylation and cell cycle progression. In xeongraft mice models, PD 0332991 treated mice had significantly decreased angiogenesis and vascular density compared with the control group, but the mechanism remains unknown. The purpose of this study is to investigate the role and molecular mechanism of PD 0332991 on vascular endothelial cells.
Methods:
EA.hy926 cells, a kind of vascular endothelial cell, were used as the research model. The effects of PD 0332991 on the activity and proliferation of EA.hy926 cells were detected by the MTT, EdU assays. Wound-healing assays and transwell assays were used to determine the effects of PD 0332991 on the mobility of EA.hy926. The influence of PD 0332991 on cell cycle and apoptosis of endothelial cells was tested by flow cytometry, and the Western blot was applied to observe the expression of cell cycle related proteins in EA.hy926 cells treated by PD 0332991.
Results:
PD 0332991 significantly inhibited the proliferation and mobility of EA.hy926 cells, caused cell cycle arrest and apoptosis. At the same time, PD 0332991 inhibited the expression of CDK4/6 and phosphorylation of Rb, and thus inhibited the cell cycle progression of EA.hy926 cells.
Conclusions:
PD 0332991 can inhibit the proliferation and activity of endothelial cells and induces apoptosis.
Insights
PD 0332991 inhibits vascular endothelial cell proliferation and mobility by blocking cell cycle progression. This cell cycle inhibitor induces apoptosis, offering potential therapeutic insights for angiogenesis-related diseases.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tumorigenesis involves angiogenesis, a process crucial for tumor growth.
- PD 0332991, a cell cycle inhibitor, targets cyclin-dependent kinases 4/6 (CDK4/6) phosphorylation.
- Previous studies indicated PD 0332991 reduces angiogenesis in vivo, but its mechanism on endothelial cells was unclear.
Purpose of the Study:
- To investigate the role of PD 0332991 in regulating vascular endothelial cell behavior.
- To elucidate the molecular mechanisms underlying PD 0332991's effects on endothelial cells.
Main Methods:
- Utilized EA.hy926 vascular endothelial cells as a model system.
- Assessed cell proliferation, mobility, cell cycle, and apoptosis using MTT, EdU, wound-healing, transwell, and flow cytometry assays.
- Analyzed cell cycle-related protein expression via Western blot.
Main Results:
- PD 0332991 significantly inhibited EA.hy926 cell proliferation and migration.
- The drug induced cell cycle arrest and apoptosis in endothelial cells.
- PD 0332991 suppressed CDK4/6 expression and Rb phosphorylation, hindering cell cycle progression.
Conclusions:
- PD 0332991 effectively inhibits vascular endothelial cell proliferation and activity.
- The compound induces apoptosis in endothelial cells, suggesting a role in anti-angiogenesis therapies.
Related Concept Videos
01:30Apoptosis
02:36Cells Coordinate Growth and Proliferation
01:26PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
02:23Abnormal Proliferation
01:18Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
03:24Seedless Vascular Plants